The DOI matches its Crossref record; 150 of the 152 references it cites were found in a registry or an index.
Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)
Abstract
People with severe mental illnesses, such as schizophrenia, depression or bipolar disorder, have worse physical health and reduced life expectancy compared to the general population. The excess cardiovascular mortality associated with schizophrenia and bipolar disorder is attributed in part to an increased risk of the modifiable coronary heart disease risk factors; obesity, smoking, diabetes, hypertension and dyslipidaemia. Antipsychotic medication and possibly other psychotropic medication like antidepressants can induce weight gain or worsen other metabolic cardiovascular risk factors. Patients may have limited access to general healthcare with less opportunity for cardiovascular risk screening and prevention than would be expected in a non-psychiatric population. The European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) published this statement with the aim of improving the care of patients suffering from severe mental illness. The intention is to initiate cooperation and shared care between the different healthcare professionals and to increase the awareness of psychiatrists and primary care physicians caring for patients with severe mental illness to screen and treat cardiovascular risk factors and diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Research into the health effects of recession has suggested that consequences will be most severe for the poorest groups in society and will have the most impact where social safety-nets are lacking and public hardship grows rapidly.64,65”
From Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000–2014 (2017) · cites this paper as [65]
In the citing paper
“The efficacy of such multidisciplinary lifestyle interventions in reducing the risk of cardiometabolic-related morbidity in the general population is well established.189”
From The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness (2019) · cites this paper as [189]
In the citing paper
“Metformin reduces the risk of transition from pre-diabetes to T2D 189,190”
From The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness (2019) · cites this paper as [189]
In the citing paper
“An example of gold-standard lifestyle intervention in the general population is the Diabetes Prevention Program (DPP) developed and evaluated in the USA.189”
From The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness (2019) · cites this paper as [189]
Citations
Cites
1 retracted
RETRACTED: Obesity and physical activity: A review
Bensimhon, D., Kraus, W. E., & Donahue, M. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.03.005 · Cited by 122
RetractedReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“- Document téléchargé le 23/06/2011 par AS OF EUROPEAN diabetes [78,131].”
BackgroundEffectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
2007 Guidelines for the Management of Arterial Hypertension
Mancia, G., Backer, G. D., Dominiczak, A. F., Cífková, R., Fagard, R. H., Germanò, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,870
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,865
Self-citationThe Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
Diagnosis and Classification of diabetes mellitus
Rossi, G. (2014) · Diapedia.org eBooks · doi:10.14496/dia..20 · Cited by 3,212
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Rozanski, A., Blumenthal, J. A., & Kaplan, J. (1999) · Circulation · doi:10.1161/01.cir.99.16.2192 · Cited by 2,846
Research works printed but not linked: 8
- 10.1176/ajp.2006.163.4.611 · DOI
- Scheen, 2008, Traitement neuroleptique et troubles metabolic, Med Mal Metabol, 2, 593
- Correll, 2008, Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents, J Clin Psychiatry, 69, 26
- Citrome, 2007, Risk-Benefit Analysis of Available Treatments for Schizophrenia, Psychiatric Times, 1, 27
- 2008, Clinical Practice Guidelines for the prevention and management of diabetes in Canada, Can J Diabetes, 32, S1
- Casey, 2004, Antipsychotic-Induced Weight Gain and Metabolic Abnormalities: Implications for Increased Mortality in Patients With Schizophrenia, J Clin Psychiatry, 65, 4
- Henderson, 2005, Schizophrenia and comorbid metabolic disorders, J Clin Psychiatry, 66, 11
- Nicol, 2009, Preliminary results of the MEAC study: metabolic effects of antipsychotics in children, Schizophr Bull, 35, 32
Cited by
Sorted by citations
Items 801–900 of 948
Lithium in older patients: treatment patterns and somatic adverse effects
van Melick, E. J. M. (2014) · Utrecht University Repository (Utrecht University)
Management of elevated blood cholesterol in the psychiatric patient: What's new in the guidelines?
Sebaaly, J. (2014) · Mental Health Clinician · doi:10.9740/mhc.n194571
Gomes, F. A. (2012) · Americanae (AECID Library)
Cg, N., Pl, C., & Ma, S. (2015) · The Malaysian journal of psychiatry
Beleslin, B., Deljanin, M., Kanjuh, V., Parapid, B. J., Giga, V. L., Prostran, M. S., Angelkov, L., Balinovac, J., Bikicki, M., Ambrosio, G., et al. (2013)
Childhood schizophrenia: diagnostic and treatment challenges
Caplan, R. (2011) · Cutting Edge Psychiatry in Practice · doi:10.65031/jmkt3113
Routinebildgebung erstdiagnostizierter Psychosepatienten
Naber, D. (2011)
Klassifikation und Diagnostik inklusive Früherkennung
DGBS, & DGPPN (2013) · Springer eBooks · doi:10.1007/978-3-642-37774-7_4
Prevalência de perfis lipídico e glicémico alterados em pacientes com esquizofrenia
Amorim, M. M., Moreira, A., Monteiro, P. R. R., Curral, R., & Marques, A. J. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Preventive Health Care among Canadian Adults with Schizophrenia and Related Disorders
Beck, C. A. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/27428
Kartlegging av kardiovaskulær risiko i en akutt psykoseenhet og videreføring av informasjon til DPS
Noor, N., Bahonjic, E., Eeg, I. K., Fløystad, H. K., Røe, Å. T., Selnes, H., & Snekvik, B. V. (2015) · NORA - Norwegian Open Research Archives
Schizophrenia: Metabolic Consequences
Ventriglio, A., Bellomo, A., & Bhugra, D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-097086-8.27063-3
Kardiovaskuläres Risikomanagement bei schweren psychischen Störungen
Müller, B., Baciu, D., & Saner, H. E. (2010) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2010.07300
Cardiometabole risicofactoren, psychiatrische stoornissen en antipsychotische medicatie
Binder, M. D., & Vancampfort, D. (2012) · Lirias (KU Leuven)
Mily, S., Mary, L., Cira, L., & Arvelo, C. (2010)
Fysieke fitheid bij patiënten met schizofrenie, aanbevelingen voor verpleegkundigen
Willems, J. B., Vancampfort, D., & Binder, M. D. (2012) · Lirias (KU Leuven)
Rate of general medical conditions in a sample of psychiatric outpatients in a general hospital
Hashim, H. M., & Fwzy, N. M. (2013) · Middle East Current Psychiatry · doi:10.1097/01.xme.0000426531.96773.ca
Mental Illness and Medical Co-morbidity Using Automated Surveillance Data: BioSense 2008 – 2011
Dey, A. N., Grigoryan, A., Park, S.-Y., Benoit, S. R., Gould, D. W., & Ajani, U. A. (2014) · Advances in Research · doi:10.9734/air/2015/13710
Cardiovascular Risk Reduction in Patients With Severe Mental Illness
Hughes, S. C., & Himmelfarb, C. D. (2011) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e3182280f9d
Nover, C. H. (2015) · J. Willard Marriott Library · doi:10.26053/0h-9ge7-c1g0
Physical Activity and Quality of Life of Outpatients with Schizophrenia
Gomes, E. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/rp0s-8s94
Evaluación y seguimiento hematológico del paciente con diagnóstico de esquizofrenia
Martinez, N. T., Peñaranda, A. P. B., Valencia, J. G., González, L. E. J., Ávila, M. J., Gómez–Restrepo, C., & González, M. L. A. (2015) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2015.05.007
Santini, I., Stratta, P., Lauretis, I. D., Santarelli, V., Pacitti, F., & Rossi, A. (2016)
Risque cardiométabolique, affections psychiatriques et antipsychotiques
Binder, M. D., & Vancampfort, D. (2012) · Lirias
Miniati, M., Calugi, S., & Mariani, G. (2015)
Inoue, S. (2014) · Journal of Diabetes and Obesity · doi:10.15436/2376-0494.14.011
Physical Comorbidities and Mood Disorders in Older Adults
Dols, A., & Sonnenberg, C. (2016) · Mental health and illness worldwide · doi:10.1007/978-981-10-0370-7_15-1
Complexities and conundrums in mental health
Titmarsh, S. (2017) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.468
Pješčić, K. D., Gutovic, J., Tesic, J., Djukić, A., Grbić, I., & Cvetković, J. (2016) · Praxis medica · doi:10.5937/pramed1602083d
Evaluation of the Healthy-Heart, Healthy-Brain Program
Kaewbua, S. (2017) · UKnowledge (University of Kentucky)
Huzayyin, A. A. S. (2013) · TSpace (University of Toronto)
Activité physique et schizophrénie: preuves scientifiques et directives
Vancampfort, D., Knapen, J., Probst, M., & Binder, M. D. (2011)
Bae, H. H., Yoon, H. J., Park, E., & Lee, J. I. (2017) · Korean Journal of Schizophrenia Research · doi:10.16946/kjsr.2017.20.1.5
Dehghani, A., Feli, S. N., Hachesu, V. R., Ardekani, M. Y., Mirzaei, M., Fallahzadeh, H., & Nough, H. (2018)
Conundrums in Managing Early Stages of Schizophrenia
Palaniyappan, L. K., Sabesan, P., Norman, R. M. G., & Hasan, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-70311-4_10
A CASE STUDY ON SCHIZOPHRENIA INDUCED MULTIPLE COMORBIDITIES
Jagadeesan, M., Rathinam, K. K., & Abraham, J. J. (2018) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2018.v11i6.23979
Troubles mentaux sévères et qualité des soins en oncologie
Lemogne, C. (2018) · Psycho-Oncologie · doi:10.3166/pson-2018-0033
Investigation of the genetic basis of schizophrenia and cognitive function
Whitton, L. (2019) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/15888
„Es fehlen spezielle Programme zur Lebensstiländerung“
Medizin, S. (2016) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-016-1626-7
Taylor, E. K. (2018) · Research Online (University of Wollongong)
Николаевна, Г. Л., Tsarenko, M. A., Литвинов, А. В., & Василенко, Л. М. (2019) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2019-2-37-45
Antipsychotics and Cardiac Side Effects
Mascolo, A., Scavone, C., Rafaniello, C., & Capuano, A. (2019) · Springer eBooks · doi:10.1007/978-3-319-90305-7_47-1
Pharmakotherapie und andere somatische Behandlungsverfahren (Modul 4a)
Gäebel, W., Hasan, A., & Falkai, P. (2019) · Springer eBooks · doi:10.1007/978-3-662-59380-6_5
Marshall, L. J. (2019) · UEA Digital Repository (University of East Anglia)
Pharmacogenetic Tests for Antipsychotic-Induced Weight Gain
Журавлева, Е. О., Velts, N. Y., Снегирева, И. И., Кутехова, Г. В., & Alyautdin, R. N. (2019) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-019-02059-z
Hasan, A., & Wobrock, T. (2016) · Elsevier eBooks · doi:10.1016/b978-3-437-22305-1.00003-x
Cardiovascular Manifestations in Schizophrenia
Calorio, F., Catania, C. G., & Rocchetti, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-28008-6_24
Antipsychotics, Weight Gain and Metabolic Risk
Cooper, S. J., & Reynolds, G. P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623465.023
Структура основных причин летальности больных шизофренией в г. Москве (2007-2013 гг. )
Олегович, Щ. В., & Валерьевич, М. А. (2014) · Российский психиатрический журнал
Vignapiano, A., Mautone, A., Vitulano, L., & Corrivetti, G. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.09.604
Herstelgericht ondersteunen van het dagelijks functioneren
Wunderink, C., & van der Meer, E. M. (2021) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2586-3_18
Tous‐Espelosin, M., de Azúa, S. R., Iriarte‐Yoller, N., Sánchez, P., Elizagárate, E., Sampedro, A., & Maldonado‐Martín, S. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111390
Parvathy, R., Sugetha, B., & Ramachandran, P. (2020) · INDIAN JOURNAL OF MENTAL HEALTH AND NEUROSCIENCES · doi:10.32746/ijmhns.2020.v3.i1.44
Kang, J. Y. (2020) · Digital Scholarship - UNLV (University of Nevada Reno) · doi:10.34917/5363910
Qubad, M., & Bittner, R. A. (2021) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/bmr2a
Doenças Cardiovasculares nas Pessoas com Doença Mental Grave: A Importância do Diagnóstico
Bernardo, M. (2021) · Acta Médica Portuguesa · doi:10.20344/amp.17103
Psychiatric Diseases in Relation to Physical Illness
Chee, T. T. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_423
Klassifikation und Diagnostik inklusive Früherkennung
DGBS, & DGPPN (2020) · Springer eBooks · doi:10.1007/978-3-662-61153-1_4
Cardiovascular Manifestations in Schizophrenia
Calorio, F., Catania, C. G., & Rocchetti, M. (2020) · Springer eBooks · doi:10.1007/978-3-319-90305-7_24-1
Hamilton, S. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717949807.793455009
Höschl, C. (2010) · European Psychiatry · doi:10.1016/s0924-9338(10)71707-7
Hell, D., & Schüpbach, D. (2016) · Springer eBooks · doi:10.1007/978-3-662-48932-1_5
Psychiatric Diseases in Relation to Physical Illness
Chee, T. T. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_423-1
The Role of the Primary Care Team
Haddad, M. (2018) · Cambridge University Press eBooks · doi:10.1017/9781911623038.027
Martland, R., Onwumere, J., Stubbs, B., & Gaughran, F. (2021) · Research Square · doi:10.21203/rs.3.rs-455096/v1
Antipsychotics and Cardiac Side Effects
Mascolo, A., Scavone, C., Rafaniello, C., & Capuano, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-28008-6_47
Skin-Gut-Breast Microbiota Axes
Drago, L. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-0899-3
Targeting Metabolic Abnormalities in Mental Health Prevention Strategies
Schimmenti, S., Maselli, F. M. C., & Tosato, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-97906-5_13
Metabolic disturbances during treatment with second generation antipsychotics
Manusheva, N., Babinkostova, Z., Arsova, S., Hadjihamza, K., Naumovska, A., & Markovic, S. (2022) · Archives of Public Health · doi:10.3889/aph.2022.6041
Cabassa, L. J. (2023) · doi:10.1093/oso/9780190937300.002.0008
Cabassa, L. J. (2023) · doi:10.1093/oso/9780190937300.003.0001
Cabassa, L. J. (2023) · doi:10.1093/oso/9780190937300.002.0006
“They Do Not Get the Care That They Need”
Cabassa, L. J. (2023) · doi:10.1093/oso/9780190937300.003.0004
Cabassa, L. J. (2023) · doi:10.1093/oso/9780190937300.002.0003
Flattening the Mortality Curve
Cabassa, L. J. (2023) · doi:10.1093/oso/9780190937300.003.0008
Cycles of Unhealthy Behaviors in Unhealthy Environments
Cabassa, L. J. (2023) · doi:10.1093/oso/9780190937300.003.0002
Cabassa, L. J. (2023) · doi:10.1093/oso/9780190937300.003.0007
Engaging in Healthy Lifestyles
Cabassa, L. J. (2023) · doi:10.1093/oso/9780190937300.003.0005
“It Cures You in One Way and It Damages You in Another”
Cabassa, L. J. (2023) · doi:10.1093/oso/9780190937300.003.0003
Cabassa, L. J. (2023) · doi:10.1093/oso/9780190937300.002.0005
Zelfmanagementondersteuning bij diabetes mellitus
van Staa, A., Sattoe, J. N. T., & de Lange-Ranzijn, M. (2023) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2919-9_5
Urinary stone disease burden is increased in patients with cognitive impairment.
Elshafei, A., Chalfant, V., Al‐Toubat, M., Riveros, C., Feibus, A. H., Bazargani, S. T., Jazayeri, S. B., Marino, R., & Balaji, K. C. (2023) · PubMed Central
Ponte, C. D., & Dang, D. K. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch21
Siddiqi, N., Stadler, M., & Holt, R. I. G. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch65
Self-citationSanjeevi, S., Zubir, M. M., Bennett, R., Cevikel, P., Nor, N., & Cocoman, A. M. (2024) · British Journal of Mental Health Nursing · doi:10.12968/bjmh.2022.0014
Physical Health of Patients with Schizophrenia
Mohr, P., Štuhec, M., & Bitter, I. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009067287.014
Brown, J. V. E., Ajjan, R., Siddiqi, N., Kellar, I., & Coventry, P. A. (2024) · medRxiv · doi:10.1101/2024.05.16.24307473
Kölblinger, F., Schönthaler, E. M. D., Baranyi, A., Stross, T. M., Fellendorf, F. T., von Lewinski, D., Queissner, R., Reininghaus, E. Z., & Dalkner, N. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i19.3824
Vasile, A., Rarinca, V., Burlui, V., Halitchi, G., Ciobica, A. S., Sîngeap, A.-M., Dobrin, R., Burlui, E., & Trifan, A. V. (2024) · Preprints.org · doi:10.20944/preprints202407.2111.v1
Cirulli, F., Ciacchella, C., & Collacchi, B. (2024) · Sustainable development goals series · doi:10.1007/978-3-031-70165-8_20
Promotion of Physical Health and Healthy Lifestyle Behaviors in Patients with Mental Disorders
Luciano, M., Rocca, B. D., Vincenzo, M. D., Toni, C., Sampogna, G., & Fiorillo, A. (2024) · Sustainable development goals series · doi:10.1007/978-3-031-70165-8_14
Severe Mental Disorders and Cardiovascular Diseases
Kuzman, M. R., & Medved, S. (2025) · Springer eBooks · doi:10.1007/978-3-031-81802-8_10
Metabolische unerwünschte Arzneimittelwirkungen von Psychopharmaka
Gahr, M. (2025) · Diabetes aktuell · doi:10.1055/a-2539-1129
Can we run away from the metabolic side effects of antipsychotics?
Akcan, M., & Wright, D. C. (2025) · Translational Exercise Biomedicine · doi:10.1515/teb-2025-0016
Liver fibrosis evaluation in patients with psychiatric diseases
Carrier, P., Chalange, M., Girard, M. F., Prémaud, A., Okassa, M., Lacroix, A., Debette‐Gratien, M., Plansont, B., Buisson, A., Calvet, B., et al. (2025) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2025.102636
Medication review in psychiatric patients with diabetes
Lam, Y. W. F. (2025) · The Brown University Psychopharmacology Update · doi:10.1002/pu.31333
Troubles bipolaires et pathologies somatiques : de l'intérêt d'une approche globale
et, S. G., & Porta-Bonete, F. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77180-4.00035-4
Metadata
- Authors
- De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J.
- Affiliations
- KU Leuven (BE)
- Imperial College London (GB)
- Medizinische Hochschule Hannover (DE)
- University of Southampton (GB)
- Ludwig-Maximilians-Universität München (DE)
- ORCID
- Venue
- European Psychiatry
- Publisher
- Cambridge University Press (CUP)
- Published
- 2009-09
- Volume
- 24
- Issue
- 6
- Pages
- 412-424
- ISSN
- 0924-9338 (ISSN-L)
- 1778-3585
- OpenAlex
- W2154493342
- Cited by
- 951
- References
- 152
- Citations by year
- 2026: 27 · 2025: 32 · 2024: 37 · 2023: 61 · 2022: 42 · 2021: 64 · 2020: 59 · 2019: 62 · 2018: 46 · 2017: 44 · 2016: 69 · 2015: 63 · 2014: 71 · 2013: 66 · 2012: 65
- FWCI
- 42.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- Lirias (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- European Society of Cardiology
- European Association for the Study of Diabetes
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- severe mental illness, cardiovascular disease, diabetes mellitus, schizophrenia, bipolar disorder, depression, cardiovascular risk factors, antipsychotic-induced weight gain, psychotropic drugs, cardiovascular risk screening, cardiovascular disease prevention, shared care, life expectancy, coronary artery disease
- MeSH terms
- Bipolar Disorder, Cardiovascular Diseases, Cause of Death, Cross-Sectional Studies, Major Depressive Disorder, Diabetes Mellitus, Follow-Up Studies, Humans, Mass Screening, Obesity, Psychotic Disorders, Psychotropic Drugs, Risk Factors, Schizophrenia, Societies, Medical, Comorbidity, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review